(Q44330393)

2 December 2017

Kappa opioid receptor immunoreactivity in the nucleus accumbens and caudate-putamen is primarily associated with synaptic vesicles in axons (English)

1 reference

2 December 2017

0 references

0 references

1 reference

Meshul CK

1

1 reference

PubMed ID

10683414

2 December 2017

McGinty JF

series ordinal

2

1 reference

PubMed ID

10683414

2 December 2017

language of work or name

English

0 references

publication date

1 January 2000

1 reference

2 December 2017

1 reference

2 December 2017

96

1 reference

2 December 2017

1

1 reference

2 December 2017

91-99

1 reference

The kappa-opioid receptor is primarily postsynaptic: combined immunohistochemical localization of the receptor and endogenous opioids

2 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2899%2990481-5

7 January 2021

Resolution and limitations of the immunoperoxidase procedure in the localization of extracellular matrix antigens

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2899%2990481-5

7 January 2021

Kappa opioid receptor-like immunoreactivity is present in substance P-containing subcortical afferents in guinea pig dentate gyrus

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2899%2990481-5

7 January 2021

Kappa opioid receptor-like immunoreactivity in guinea pig brain: ultrastructural localization in presynaptic terminals in hippocampal formation

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2899%2990481-5

7 January 2021

U-50,488H inhibits dynorphin and glutamate release from guinea pig hippocampal mossy fiber terminals

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2899%2990481-5

7 January 2021

Kappa opioid inhibition of morphine and cocaine self-administration in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2899%2990481-5

7 January 2021

The kappa-opioid agonist, U-69593, decreases acute amphetamine-evoked behaviors and calcium-dependent dialysate levels of dopamine and glutamate in the ventral striatum

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2899%2990481-5

7 January 2021

The kappa-opioid receptor agonist U-69593 attenuates cocaine-induced behavioral sensitization in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2899%2990481-5

7 January 2021

Modulation of glutamate release by a kappa-opioid receptor agonist in rodent and primate striatum.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2899%2990481-5

7 January 2021

Pre- and postsynaptic inhibition by opioids in rat striatum

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2899%2990481-5

7 January 2021

AMPA/kainate antagonists in the nucleus accumbens inhibit locomotor stimulatory response to cocaine and dopamine agonists.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2899%2990481-5

7 January 2021

Reverse tolerance to amphetamine evokes reverse tolerance to 5-hydroxytryptophan

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2899%2990481-5

7 January 2021

Kappa-opioid receptor agonist U50,488H modulates cocaine and morphine self-administration in drug-naive rats and mice

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2899%2990481-5

7 January 2021

U50,488, a kappa opioid receptor agonist, attenuates cocaine-induced increases in extracellular dopamine in the nucleus accumbens of rats

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2899%2990481-5

7 January 2021

Functional implications of kappa opioid receptor-mediated modulation of glutamate transmission in the output regions of the basal ganglia in rodent and primate models of Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2899%2990481-5

7 January 2021

Immunohistochemical localization of the cloned kappa 1 receptor in the rat CNS and pituitary.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2899%2990481-5

7 January 2021

Cloning and pharmacological characterization of a rat kappa opioid receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2899%2990481-5

7 January 2021

Time-dependent changes in striatal glutamate synapses following a 6-hydroxydopamine lesion.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2899%2990481-5

7 January 2021

In situ hybridization study of kappa-opioid receptor mRNA in the rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2899%2990481-5

7 January 2021

κ and δ-opioid receptor agonists differentially inhibit striatal dopamine and acetylcholine release

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2899%2990481-5

7 January 2021

Autoradiography of [3H]U-69593 binding sites in rat brain: evidence for kappa opioid receptor subtypes

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2899%2990481-5

7 January 2021

DAB cytochemistry: artifact problems in its current uses

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2899%2990481-5

7 January 2021

Repeated cocaine augments excitatory amino acid transmission in the nucleus accumbens only in rats having developed behavioral sensitization.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2899%2990481-5

7 January 2021

Kappa receptor activation attenuates L-trans-pyrrolidine-2,4-dicarboxylic acid-evoked glutamate levels in the striatum.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2899%2990481-5

7 January 2021

Presynaptic kappa-opioid and muscarinic receptors inhibit the calcium-dependent component of evoked glutamate release from striatal synaptosomes

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2899%2990481-5

7 January 2021

Molecular biology of opioid receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2899%2990481-5

7 January 2021

Stimulus-dependent translocation of kappa opioid receptors to the plasma membrane.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2899%2990481-5

7 January 2021

Opposing tonically active endogenous opioid systems modulate the mesolimbic dopaminergic pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2899%2990481-5

7 January 2021

Cellular sites for activation of delta-opioid receptors in the rat nucleus accumbens shell: relationship with Met5-enkephalin.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2899%2990481-5

7 January 2021

Neuroanatomical localization ofκ1and κ2 opioid receptors in rat and guinea pig brain

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2899%2990481-5

7 January 2021

Coadministration of MK-801 with amphetamine, cocaine or morphine prevents rather than transiently masks the development of behavioral sensitization.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2899%2990481-5

7 January 2021

10.1016/S0306-4522(99)90481-5

Identifiers

DOI

1 reference

2 December 2017

1 reference

PubMed ID

10683414